CIK 0001534120
- Non-accelerated filer
- Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450705648
- Phone
- +1 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,474
- in 3 filings, $395K under 10b5-1 plans
Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-31 | Almenoff June Sherie Director | Grant or award · Stock Option (Right to Buy) | +737 | 737 | ||
| 2021-12-31 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +7,943 | 7,943 | ||
| 2021-12-31 | Miller Joseph M Director | Grant or award · Stock Option (Right to Buy) | +8,920 | 8,920 | ||
| 2021-12-31 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +12,767 | 12,767 | ||
| 2021-12-10 | Wilkins H Jeffrey Chief Medical Officer | Purchase | +6,371 | $1.57 | $10K | 33,373 |
| 2021-12-10 | Sullivan Christopher Ryan Chief Accounting Officer | Purchase | +955 | $1.57 | $1K | 9,004 |
| 2021-12-10 | Harrell James Archie Jr Chief Commercial Officer | Purchase | +1,093 | $1.57 | $2K | 36,766 |
| 2021-12-10 | NEIL GARRY ARTHUR Chief Scientific Officer | Purchase | +4,267 | $1.57 | $7K | 85,639 |
| 2021-12-10 | Greenway Schond L. CFO | Purchase | +2,231 | $1.57 | $4K | 3,883 |
| 2021-12-01 | Chan Mitchell Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2021-11-10 | Almenoff June Sherie Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2021-10-01 | COLA MICHAEL F Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +78,116 | 78,116 | ||
| 2021-09-30 | Bruhn Suzanne Louise Director | Grant or award · Stock Option (Right to Buy) | +5,204 | 5,204 | ||
| 2021-09-30 | Gutry Phil Director | Grant or award · Stock Option (Right to Buy) | +4,718 | 4,718 | ||
| 2021-09-30 | Miller Joseph M Director | Grant or award · Stock Option (Right to Buy) | +6,939 | 6,939 | ||
| 2021-09-30 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +5,985 | 5,985 | ||
| 2021-09-30 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +9,541 | 9,541 | ||
| 2021-09-17 | ARMISTICE CAPITAL, LLC Director | Purchase | +5,454,545 | $2.20 | $12.0M | 45,000,000 |
| 2021-09-16 | ARMISTICE CAPITAL, LLC Director | Purchase | +150,000 | $2.28 | $342K | 39,545,455 |
| 2021-09-15 | ARMISTICE CAPITAL, LLC Director | Purchase | +95,455 | $2.26 | $216K | 39,395,455 |
Page 16 of 25 · 500 trades